Literature DB >> 15809883

Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease.

Hongmei Ren1, Iheanyi Okpala, Kebreab Ghebremeskel, Cynthia C Ugochukwu, Obike Ibegbulam, Michael Crawford.   

Abstract

Leukocyte adhesion to vascular endothelium contributes to vaso-occlusion and widespread organ damage in sickle cell disease (SCD). Previously, we found high expression of the adhesion molecules alphaMbeta2 integrin and L-selectin in HbSS individuals with severe disease. Since membrane n-6 and n-3 polyunsaturated fatty acids modulate cell adhesion, inflammation, aggregation and vascular tone, we investigated the fatty acid composition of mononuclear cells (MNC) and platelets of HbSS patients in steady state (n=28) and racially matched, healthy HbAA controls with similar age and sex distribution living in the same environment (n=13). MNC phospholipids of the patients had lower levels of docosahexaenoic acid (DHA, p<0.01) and increased arachidonic acid (AA, p<0.005) relative to HbAA controls. Similarly, platelets from HbSS patients had less eicosapentaenoic acid (EPA, p<0.05) and more AA (p<0.05) in choline phosphoglycerides (CPG), with reduced DHA (p<0.05) in ethanolamine phosphoglycerides. Platelet CPG had lower DHA levels in SCD patients with complications compared to those without (p<0.05). Reduced cell content of EPA and DHA relative to AA favours the production of aggregatory and proinflammatory eicosanoids that activate leukocytes and platelets. This facilitates inflammation, leukocyte adhesion, platelet aggregation and vaso-occlusion in SCD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809883     DOI: 10.1007/s00277-005-1023-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  10 in total

1.  Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial).

Authors:  Ahmed A Daak; Carlton D Dampier; Beng Fuh; Julie Kanter; Ofelia A Alvarez; L Vandy Black; Melissa A McNaull; Michael U Callaghan; Alex George; Lynne Neumayr; Lee M Hilliard; Fredrick Sancilio; Adrian L Rabinowicz; Matthew M Heeney
Journal:  Blood Adv       Date:  2018-08-14

2.  Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia.

Authors:  B N Yamaja Setty; Suhita Gayen Betal; Robin E Miller; Dawn S Brown; Maureen Meier; Michele Cahill; Norma B Lerner; Nataly Apollonsky; Marie J Stuart
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2019-05-10       Impact factor: 4.006

3.  LC-MS/MS analysis of plasma polyunsaturated fatty acids in patients with homozygous sickle cell disease.

Authors:  Mutay Aslan; Gamze Celmeli; Filiz Özcan; Alphan Kupesiz
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

Review 4.  Functional foods: promising therapeutics for Nigerian Children with sickle cell diseases.

Authors:  Oladeji John Alabi; Fikayo Noah Adegboyega; Dolapo Samuel Olawoyin; Oluwakemi Arinola Babatunde
Journal:  Heliyon       Date:  2022-06-02

Review 5.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

6.  Hydroxyurea therapy mobilises arachidonic Acid from inner cell membrane aminophospholipids in patients with homozygous sickle cell disease.

Authors:  A A Daak; K Ghebremeskel; M I Elbashir; A Bakhita; Z Hassan; M A Crawford
Journal:  J Lipids       Date:  2011-09-15

7.  Addition of multimodal therapy to standard management of steady state sickle cell disease.

Authors:  Iheanyi Okpala; Osita Ezenwosu; Anthony Ikefuna; Augustine Duru; Barth Chukwu; Anazoeze Madu; Theresa Nwagha; Sunday Ocheni; Obike Ibegbulam; Ifeoma Emodi; Uche Anike; Charles Nonyelu; Chukwudi Anigbo; Kingsley Agu; Ifeoma Ajuba; Awele Chukwura; Ogechukwu Ugwu; Uche Ololo
Journal:  ISRN Hematol       Date:  2013-12-09

8.  Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease.

Authors:  Nancy J Wandersee; Jamie L Maciaszek; Katie M Giger; Madelyn S Hanson; Suilan Zheng; YiHe Guo; Barbara Mickelson; Cheryl A Hillery; George Lykotrafitis; Philip S Low; Neil Hogg
Journal:  Blood Cells Mol Dis       Date:  2014-11-25       Impact factor: 3.039

Review 9.  Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration.

Authors:  Shahida A Khan; Ghazi Damanhouri; Ashraf Ali; Sarah A Khan; Aziz Khan; Ahmed Bakillah; Samy Marouf; Ghazi Al Harbi; Saeed H Halawani; Ahmad Makki
Journal:  Nutr Metab (Lond)       Date:  2016-08-08       Impact factor: 4.169

10.  Coagulation profile of Sudanese children with homozygous sickle cell disease and the effect of treatment with omega-3 fatty acid on the coagulation parameters.

Authors:  Shiekh Awoda; Ahmed A Daak; Nazik Elmalaika Husain; Kebreab Ghebremeskel; Mustafa I Elbashir
Journal:  BMC Hematol       Date:  2017-11-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.